Filing Flows › DataMeds AI (MEDS) › Q4 2024
DataMeds AI (MEDS) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 25, 2025
DataMeds AI (MEDS) reported revenue of $12.4M for the fourth quarter 2024 (Q4 2024) and +119% from the quarter before. Operating margin was -30.2%, net loss $4.3M (34.9% of revenue).
DataMeds AI, Q4 2024: revenue $12.4M, operating margin -30.2%, net loss $4.3M, operating cash flow −$2.6M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.4M | +119% | — |
| Operating profit | −$3.7M | — | — |
| Net earnings | −$4.3M | — | — |
| Operating cash flow | −$2.6M | — | — |
What changed
Revenue was $12.4M in Q4 2024, up 119% from the previous quarter.
Gross margin was 10.1%. Operating costs exceeded revenue by $3.7M, an operating margin of -30.2%. The quarter ended with a net loss of $4.3M, wider than the previous quarter's $1.9M loss.
Operating cash flow was −$2.6M. Non-cash charges added back $647K of depreciation and amortization. Working capital and other items added $1.1M.
Questions
What was DataMeds AI's revenue in the fourth quarter 2024?
DataMeds AI (MEDS) reported revenue of $12.4M for the fourth quarter 2024 (Q4 2024) and +119% from the quarter before.
Was DataMeds AI profitable in the fourth quarter 2024?
Operating loss was $3.7M (-30.2% of revenue) and net loss $4.3M.
Source: DataMeds AI 10-K on SEC EDGAR.